Parkinson's disease, which robs people of control over their movements, usually starts in middle or late life and develops slowly.
Parkinson's itself does not kill, but eventually when medication loses its effect a patient can become bedridden and could die from complications.
Parkinson's disease at a glance "As someone with Parkinson's disease who for four years has had GDNF as my big hope, it's absolutely devastating," Tom Isaacs, co-founder of the Cure Parkinson's Trust in England, said of Amgen's decision.
Parkinson's is a degenerative disease of the nervous system, affecting more than one percent of people over the age of
